Annual Report

Overview

The report highlights AJJ Medtech's 43.8% revenue growth to S$2.32 million in FY2024, driven by healthcare equipment and services, strategic acquisitions and product innovation. It describes expansion across point-of-care diagnostics, ultrasound, medical devices and dental devices, including placement of its blood-glucose system in 40 major public health institutes. The report also presents ESG priorities spanning product quality and safety, affordable healthcare, inclusion and diversity, sustainable supplier practices, and patient-data protection.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 31 December 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services